Molecular Cancer Therapeutics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Braun, D. C.
Right arrow Articles by Blumberg, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Braun, D. C.
Right arrow Articles by Blumberg, P. M.
Mol Cancer Ther. 2005;4:141-150
© 2005 American Association for Cancer Research

Role of phorbol ester localization in determining protein kinase C or RasGRP3 translocation: Real-time analysis using fluorescent ligands and proteins

Derek C. Braun1,2, Yeyu Cao4, Shaomeng Wang4, Susan H. Garfield3, Gang Min Hur2 and Peter M. Blumberg2

1 Department of Biology, Gallaudet University, Washington, District of Columbia; Laboratories of 2 Cellular Carcinogenesis and Tumor Promotion and 3 Experimental Carcinogenesis, National Cancer Institute, NIH, Bethesda, Maryland; 4 Departments of Internal Medicine and Medicinal Chemistry and Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan

Requests for reprints: Peter M. Blumberg, National Cancer Institute, NIH, Building 37, Room 4048, 37 Convent Drive, MSC 4255, Bethesda, MD 20892-4255. Phone: 301-496-3189; Fax: 301-496-8709. E-mail: blumberp{at}dc37a.nci.nih.gov

The diacylglycerol signaling pathway, involving protein kinase C (PKC) and RasGRP, is a promising therapeutic target for both cancer and other indications. The phorbol esters, ultrapotent diacylglycerol analogues, bind to and activate PKC and RasGRP. Here, using fluorescent phorbol esters and complementary fluorescent PKC and RasGRP constructs, we determined the localization of the phorbol ester as a function of time after addition and how the resultant PKC or RasGRP3 translocation related to ligand localization. For these studies, we prepared fluorescently labeled phorbol esters of varying lipophilicities based on the BODIPY FL (green) or BODIPY 581/591 (red) fluorophores, and by using fusion constructs of green fluorescent protein or DsRed with PKC isoforms or RasGRP3 expressed in Chinese hamster ovary cells, we simultaneously compared the kinetics and pattern of localization of PKC or RasGRP3 with that of the fluorescent red or green phorbol esters. Binding assays showed that the fluorescent derivatives were potent ligands. Uptake followed a one-compartment pharmacokinetic model with a half-time of minutes to hours, depending on the ligand, and all of the fluorescent phorbol esters localized primarily to intracellular membranes, with little plasma membrane localization. The fluorescent phorbol esters induced translocation of and generally colocalized with PKC{delta} or RasGRP3. However, PKC{alpha} and, initially, PKC{delta}, translocated to the plasma membrane, in which little phorbol ester accumulated. The findings argue that the rate of uptake of phorbol esters influences the subsequent pattern of PKC{delta} translocation, and that the specificity for PKC{alpha} translocation is dominated by factors other than the localization of the ligand.


Key Words: phorbol ester • protein kinase C • green fluorescent protein • subcellular localization, kinetics • uptake

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 8/ 4/04; revised 10/15/04; accepted 11/ 8/04.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. M. Okamura, C. E. Oki-Idouchi, and P. S. Lorenzo
The Exchange Factor and Diacylglycerol Receptor RasGRP3 Interacts with Dynein Light Chain 1 through Its C-terminal Domain
J. Biol. Chem., November 24, 2006; 281(47): 36132 - 36139.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Pu, M. L. Peach, S. H. Garfield, S. Wincovitch, V. E. Marquez, and P. M. Blumberg
Effects on Ligand Interaction and Membrane Translocation of the Positively Charged Arginine Residues Situated along the C1 Domain Binding Cleft in the Atypical Protein Kinase C Isoforms
J. Biol. Chem., November 3, 2006; 281(44): 33773 - 33788.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Kohl, S. Preiss, A. von Knethen, and B. Brune
Oxidized low-density lipoprotein depletes PKC{alpha} and attenuates reactive oxygen species formation in monocytes/macrophages
Cardiovasc Res, August 1, 2006; 71(3): 574 - 585.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. Lazar, D. C. Braun, A. Toth, Y. Wang, L. V. Pearce, V. A. Pavlyukovets, P. M. Blumberg, S. H. Garfield, S. Wincovitch, H.-K. Choi, et al.
Kinetics of Penetration Influence the Apparent Potency of Vanilloids on TRPV1
Mol. Pharmacol., April 1, 2006; 69(4): 1166 - 1173.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
A. Collazos, B. Diouf, N. C. Guerineau, C. Quittau-Prevostel, M. Peter, F. Coudane, F. Hollande, and D. Joubert
A Spatiotemporally Coordinated Cascade of Protein Kinase C Activation Controls Isoform-Selective Translocation.
Mol. Cell. Biol., March 1, 2006; 26(6): 2247 - 2261.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
M. C. Tuthill, C. E. Oki, and P. S. Lorenzo
Differential effects of bryostatin 1 and 12-O-tetradecanoylphorbol-13-acetate on the regulation and activation of RasGRP1 in mouse epidermal keratinocytes.
Mol. Cancer Ther., March 1, 2006; 5(3): 602 - 610.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. H. Wabnitz, G. Nebl, M. Klemke, A. J. Schroder, and Y. Samstag
Phosphatidylinositol 3-Kinase Functions as a Ras Effector in the Signaling Cascade That Regulates Dephosphorylation of the Actin-Remodeling Protein Cofilin after Costimulation of Untransformed Human T Lymphocytes
J. Immunol., February 1, 2006; 176(3): 1668 - 1674.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. R. Giorgione, J.-H. Lin, J. A. McCammon, and A. C. Newton
Increased Membrane Affinity of the C1 Domain of Protein Kinase C{delta} Compensates for the Lack of Involvement of Its C2 Domain in Membrane Recruitment
J. Biol. Chem., January 20, 2006; 281(3): 1660 - 1669.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.